![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Daclatasvir and Sofosbuvir in Patients with
Recurrent HCV Following Liver Transplantation with Advanced Fibrosis or Cirrhosis:
United States Multicenter Treatment Protocol
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Kwo P,1 Fried MW,2 Reddy R,3 Soldevila-Pico C,4 Khemichian S,5 Darling J,2 Napoli A,6 Anduze-Faris B,6 Brown RS Jr7
1Indiana University, Indianapolis, IN; 2University of North Carolina, Chapel Hill, NC; 3Department of Medicine, University of Pennsylvania, Philadelphia, PA; 4Department of Medicine, University of Florida, Gainesville, FL; 5Keck School of Medicine, University of Southern California, Los Angeles, CA; 6Bristol-Myers Squibb, Plainsboro, NJ;7Department of Medicine, Columbia University College of Physicians & Surgeons, New York, NY
![AASLD1.gif](../images/120115/120115-11/AASLD1.gif)
![AASLD2.gif](../images/120115/120115-11/AASLD2.gif)
![AASLD3.gif](../images/120115/120115-11/AASLD3.gif)
![AASLD4.gif](../images/120115/120115-11/AASLD4.gif)
![AASLD5.gif](../images/120115/120115-11/AASLD5.gif)
![AASLD6.gif](../images/120115/120115-11/AASLD6.gif)
![AASLD7.gif](../images/120115/120115-11/AASLD7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|